Position in BCAX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$54,099,633
+$6,519,770 QoQ
Shares Held
1,822,150
-23.8% QoQ
Ownership
2.75%
of shares outstanding
% of Portfolio
29.14%
of 13F equity value
Holder Rank
#15
of 169 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Omega Fund Management, LLC holds $139,057,890 across 8 Biotechnology names. BCAX ranks #1 (38.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BCAX |
Bicara Therapeutics Inc.
This page
|
1,822,150 | $54,099,633 | |
| 2 | NUVB |
Nuvation Bio Inc.
|
8,081,089 | $45,900,585 | |
| 3 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
3,289,661 | $25,067,216 | |
| 4 | ALMS |
Alumis Inc.
|
241,255 | $6,788,915 | |
| 5 | SANA |
Sana Biotechnology, Inc.
|
843,750 | $2,944,687 | |
| 6 | IMA |
ImageneBio, Inc.
|
455,361 | $2,686,629 | |
| 7 | ENGN |
enGene Therapeutics Inc.
|
876,357 | $1,516,097 | |
| 8 | ODTX |
Odyssey Therapeutics, Inc.
|
2,893 | $54,128 |
All Filings in BCAX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $54,099,633 | 1,822,150 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $47,579,863 | 2,392,150 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $37,104,259 | 2,204,650 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $34,811,423 | 2,204,650 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $20,481,198 | 2,204,650 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $28,726,589 | 2,204,650 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $38,405,003 | 2,204,650 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $56,152,435 | 2,204,650 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||